Josh is a Founder and Managing Partner of CHV and has been a member of the Investment Committees of the general partners of CHV I and CHV II since 2008. He is actively involved in all aspects of fund management including investments and capital raising and has led CHV I and CHV II investments in the medical device, women’s health and molecular diagnostics markets.
He led CHV’s investments in Allegro Diagnostics (acquired by Veracyte), Vortex Medical (acquired by AngioDynamics), SevenOaks Biosystems (acquired by Medline), Sera Prognostics (NASD: SERA), Pavilion Medical, Saphena Medical, Cruzar Medsystems, Conformal Medical, Brixton Biosciences, EyeCool Therapeutics, and Epitel. He is a Director of Sera Prognostics, Pavilion Medical, Saphena Medical, and Cruzar Medsystems, and a past Director of Allegro Diagnostics, Vortex Medical, and SevenOaks Biosciences.
From 2000 to 2007, Josh was the Managing Partner of Catalyst Health and Technology Partners, LLC., an organization that made early-stage investments in healthcare and technology focused companies. Relevant investments he led include Novazyme Pharmaceuticals (acquired by Genzyme), BioTrove (acquired by Life Technologies), and Biocius Life Sciences (acquired by Agilent Technologies). He was previously the Chairman of, a Director of Biocius Life Sciences, and a Board Observer to Novazyme Pharmaceuticals.
From 1997 to 2000, he was a Manager at the Lucas Group, a boutique strategy-consulting firm, where he led engagements advising healthcare, life science, and technology-based companies. In 1990, Josh co-founded, managed, and built a new business unit at Russelectric, a privately held engineering technology firm that is now part of Siemens. In five years, the business achieved annual sales in excess of $5 million and employed 15 engineers and technicians. Josh previously held project and engineering management positions at Pratt & Whitney Aircraft, focused on the integration of hardware and software for the control system of the USAF F-22 fighter engine.
Josh received an M.B.A. from the Harvard Business School and a B.E. in Electrical Engineering and Mathematics from Vanderbilt University.